These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7163816)

  • 1. Ifosfamide in the management of malignant melanoma: a Southwest Oncology Group Phase II Study.
    Costanzi JJ; Stephens R; O'Bryan R; Franks J
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):93-5. PubMed ID: 7163816
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies with ifosfamide in patients with malignant lymphoma.
    Rodriguez V; Cabanillas F; Bodey GP; Freireich EJ
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):87-92. PubMed ID: 7163815
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicity of single- vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multi-center study.
    Morgan LR; Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Plotkin D; Tucker WG; Worrall PM
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):66-70. PubMed ID: 7163813
    [No Abstract]   [Full Text] [Related]  

  • 4. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
    Cabanillas F; Rodriguez V; Bodey GP
    Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634
    [No Abstract]   [Full Text] [Related]  

  • 5. Ifosfamide in the treatment of extensive non-oat cell carcinoma of the lung.
    Costanzi JJ; Morgan LR; Hokanson J
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):61-5. PubMed ID: 6298945
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose ifosfamide in advanced osteosarcoma.
    Marti C; Kroner T; Remagen W; Berchtold W; Cserhati M; Varini M
    Cancer Treat Rep; 1985 Jan; 69(1):115-7. PubMed ID: 3855382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy with cis-dichloro-diammineplatinum (II) and ifosfamide in malignant melanomas (author's transl)].
    Balda BR; Jehn U; Klövekorn W; Wohlrab A
    Klin Wochenschr; 1981 Jul; 59(14):781-6. PubMed ID: 7196477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of malignant melanoma with cis-diaminodichloroplatinum and ifosfamid (author's transl)].
    Berdel WE; Fink U; Emmerich B; Maubach PA; Busch U; Remy W; Rastetter J
    Dtsch Med Wochenschr; 1982 Jan; 107(1):26-8. PubMed ID: 7198963
    [No Abstract]   [Full Text] [Related]  

  • 10. Use and safety of high-dose ifosfamide.
    Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
    Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Morgan LR; Plotkin D; Tucker WG; Worrall PM
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):56-60. PubMed ID: 6298944
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide.
    Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study with ifosfamide in advanced malignant melanoma.
    Negretti E; Ferrari L; Bonfante V; Bajetta E
    Tumori; 1988 Apr; 74(2):163-5. PubMed ID: 3368970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).
    Nelson RL; Creaven PJ; Cohen MH; Fossieck BE
    Eur J Cancer (1965); 1976 Mar; 12(3):195-8. PubMed ID: 780113
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).
    Creaven PJ; Allen LM; Cohen MH; Nelson RL
    Cancer Treat Rep; 1976 Apr; 60(4):445-9. PubMed ID: 1277220
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II chemotherapy trials of 5-FU, cyclophosphamide, ifosfamide, and vincristine in carcinoma of the bilharzial bladder.
    Gad-el-Mawla N; Ziegler JL; Hamza R; Elserafi M; Khaled H
    Cancer Treat Rep; 1984 Feb; 68(2):419-21. PubMed ID: 6697330
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxorubicin and ifosfamide combination chemotherapy in previously treated acute leukemia in adults: a Southwest Oncology Group pilot study.
    Ryan DH; Bickers JN; Vial RH; Hussein K; Bottomley R; Hewlett JS; Wilson HE; Stuckey WJ
    Cancer Treat Rep; 1980; 64(8-9):869-72. PubMed ID: 7448824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
    Loehrer PJ; Williams SD; Einhorn LH
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):72-5. PubMed ID: 6836331
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
    Thigpen JT; Al-Sarraf M; Hewlett JS
    Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.